We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$46.8B
AUM Growth
+$933M
Cap. Flow
+$2.08B
Cap. Flow %
4.45%
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
452

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$255M
2
PGR icon
Progressive
PGR
+$244M
3
V icon
Visa
V
+$238M
4
LRCX icon
Lam Research
LRCX
+$201M
5
ELV icon
Elevance Health
ELV
+$190M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Healthcare 13.28%
3 Financials 10.32%
4 Industrials 9.79%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBBN icon
3376
Ribbon Communications
RBBN
$363M
-14,487
Closed -$60.3K
RCKT icon
3377
Rocket Pharmaceuticals
RCKT
$385M
-41,142
Closed -$517K
RCL icon
3378
PUT
Royal Caribbean
RCL
$78.1B
-150,000
Closed -$34.6M
REVG
3379
DELISTED
REV Group
REVG
-27,100
Closed -$864K
RGLS
3380
DELISTED
Regulus Therapeutics
RGLS
-22,264
Closed -$35.2K
RIG icon
3381
PUT
Transocean
RIG
$6.61B
-750,000
Closed -$2.81M
ROCK icon
3382
Gibraltar Industries
ROCK
$1.38B
-18,368
Closed -$1.08M
ROIV icon
3383
Roivant Sciences
ROIV
$26.2B
-12,100
Closed -$143K
ROOT icon
3384
Root
ROOT
$864M
-8,535
Closed -$620K
RPTX
3385
DELISTED
Repare Therapeutics
RPTX
-13,467
Closed -$17.6K
RSKD icon
3386
Riskified
RSKD
$779M
-25,490
Closed -$121K
RSPH icon
3387
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$826M
-24,500
Closed -$718K
RUSHA icon
3388
Rush Enterprises Class A
RUSHA
$8.54B
-3,841
Closed -$210K
SA
3389
Seabridge Gold
SA
$3.25B
-24,166
Closed -$276K
SBS icon
3390
Sabesp
SBS
$16.2B
-368,310
Closed -$1.02M
SCHA icon
3391
Schwab U.S Small- Cap ETF
SCHA
$23.1B
-16,400
Closed -$424K
SCHK icon
3392
Schwab 1000 Index ETF
SCHK
$5.89B
-438,200
Closed -$12.4M
SDHC icon
3393
Smith Douglas Homes
SDHC
$104M
-27,550
Closed -$706K
SGHT icon
3394
Sight Sciences
SGHT
$455M
-18,944
Closed -$69K
SITE icon
3395
SiteOne Landscape Supply
SITE
$4.19B
-15,689
Closed -$2.07M
FIRY
3396
Firy Inc
FIRY
$160M
-14,480
Closed -$72.8K
SKT icon
3397
Tanger
SKT
$4.39B
-120,095
Closed -$4.1M
SLP icon
3398
Simulations Plus
SLP
$372M
-11,006
Closed -$307K
SNEX icon
3399
StoneX
SNEX
$8.26B
-34,530
Closed -$1M
SOFI icon
3400
PUT
SoFi Technologies
SOFI
$24.4B
-3,092,900
Closed -$47.6M

Similar funds

John Overdeck's Q1 2025 Portfolio in Review

As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.

  • John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
  • John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
  • John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
  • John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
  • John Overdeck opened 458 new positions and closed 452 in Q1 2025.
  • John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.